V-Med Retatrutide 30MG
Retatrutide is an investigational once-weekly injection by Eli Lilly currently in Phase 3 clinical trials. Often called a "Triple-G" agonist, it uniquely targets three metabolic hormones: GLP-1, GIP, and glucagon. In trials, it has yielded an unprecedented average weight loss of up to 24-30%
Discuss this product.
The product name, SKU and current website price will be pre-filled into WhatsApp so you can complete the conversation directly with BioHack88.
Discuss & order on WhatsApp Open WhatsApp catalogue →